Atara Biotherapeutics, Inc. ATRA توقعات الأسهم
تنبؤ الأسعار والتحليل المدعوم بالذكاء الاصطناعي لـ Atara Biotherapeutics, Inc. · محدثة مايو 21, 2026
تنبؤ الذكاء الاصطناعي لـ90 يوماً
احتفاظ
7 أيام
30 يوماً
90 يوماً
ثقة الذكاء الاصطناعي: 3% ارتباط سبيرمان
مايو 21, 2026
شاهد هدف السعر الدقيق لـ ATRA
أنشئ حساباً مجانياً لفتح تنبؤات الذكاء الاصطناعي لأكثر من 4,000 سهم
سجّل مجاناً باستخدام Google✓ حساب مجاني · ✓ تجربة لمدة 30 يوماً · ✓ إلغاء في أي وقت
الرسم البياني للسعر
جاري تحميل الرسم البياني...
الإحصائيات الرئيسية
القيمة السوقية
$80M
العائد على حقوق الملكية
187,4%
الإيرادات
$23M
النسبة الجارية
2,16x
نسبة الدين إلى حقوق الملكية
-1,54x
حول Atara Biotherapeutics, Inc.
Atara Biotherapeutics, Inc. (ATRA) تعمل في قطاع Life Sciences، وتحديداً في صناعة Biological Products, (No Diagnostic Substances). .
We do not have any company description for Atara Biotherapeutics, Inc. at the moment.
آخر الأخبار
- ATRA FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Atara Biotherapeutics (ATRA) Investors of Securities Class Action Deadline on May 22, 2…
- Atara Biotherapeutics, Inc. (ATRA) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
- Atara Biotherapeutics, Inc. (ATRA) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
- سجّل مجاناً لقراءة جميع المقالات البالغ عددها 10 →
Biological Products, (No Diagnostic Substances) الشركات المماثلة
| الشركة | رمز السهم | إشارة الذكاء الاصطناعي | القيمة السوقية | نسبة السعر إلى الربح |
|---|---|---|---|---|
| Acumen Pharmaceuticals, Inc. | ABOS | ██% | $180M | -x |
| Abpro Holdings, Inc. | ABP | ██% | $310K | -x |
| Abpro Holdings, Inc. | ABPO | ██% | $1M | -x |
| Arcellx, Inc. | ACLX | ██% | $6.73B | -x |
| Alpha Cognition Inc. | ACOG | ██% | $127M | -x |
| Adaptimmune Therapeutics Plc | ADAP | ██% | $77M | -13,2x |
| Adma Biologics, Inc. | ADMA | ██% | $1.97B | 11,9x |
| Adaptive Biotechnologies Corp | ADPT | ██% | $2.21B | -x |
| Adverum Biotechnologies, Inc. | ADVM | ██% | $95M | -1,8x |
| Agenus Inc | AGEN | ██% | $122M | 1,9x |
| Agentix Corp. | AGTX | ██% | $1M | -x |
| Aim Immunotech Inc. | AIM | ██% | $4M | -x |
| Aim Immunotech Inc. | AIMI | ██% | $1M | -x |
| Alector, Inc. | ALEC | ██% | $245M | -x |
| Aligos Therapeutics, Inc. | ALGS | ██% | $35M | -x |
| Allogene Therapeutics, Inc. | ALLO | ██% | $676M | -x |
| Alvotech | ALVO | ██% | $1.05B | -x |
| Amgen Inc | AMGN | ██% | $182.11B | 23,4x |
| Apogee Therapeutics, Inc. | APGE | ██% | $6.17B | -x |
| Aptose Biosciences Inc. | APTOF | ██% | $4M | -x |
| Argenx Se | ARGX | ██% | $50.51B | -x |
| Armata Pharmaceuticals, Inc. | ARMP | ██% | $301M | -x |
| Artiva Biotherapeutics, Inc. | ARTV | ██% | $388M | -x |
| Leonabio, Inc. | ATHA | ██% | $23M | -0,2x |
| Atara Biotherapeutics, Inc. | ATRA | ██% | $80M | -x |
| Atyr Pharma Inc | ATYR | ██% | $52M | -x |
| Aura Biosciences, Inc. | AURA | ██% | $791M | -x |
| Autolus Therapeutics Plc | AUTL | ██% | $439M | -x |
| Anavex Life Sciences … | AVXL | ██% | $251M | -x |
| Bioatla, Inc. | BCAB | ██% | $6M | -x |
| Biocardia, Inc. | BCDA | ██% | $10M | -x |
| Brainstorm Cell Therapeutics … | BCLI | ██% | $9M | -x |
| Biocryst Pharmaceuticals Inc | BCRX | ██% | $2.13B | -x |
| Black Diamond Therapeutics, … | BDTX | ██% | $203M | -x |
| Beam Therapeutics Inc. | BEAM | ██% | $2.84B | -x |
| Biogen Inc. | BIIB | ██% | $27.89B | 20,3x |
| Biontech Se | BNTX | ██% | $22.99B | -x |
| Cabaletta Bio, Inc. | CABA | ██% | $602M | -x |
| Candel Therapeutics, Inc. | CADL | ██% | $581M | -x |
| C4 Therapeutics, Inc. | CCCC | ██% | $366M | -x |
| Cidara Therapeutics, Inc. | CDTX | ██% | $6.49B | -1,0x |
| Creative Medical Technology … | CELZ | ██% | $8M | -x |
| Cero Therapeutics Holdings, … | CERO | ██% | $900K | -x |
| Cullinan Therapeutics, Inc. | CGEM | ██% | $859M | -x |
| Compugen Ltd | CGEN | ██% | $247M | 3,5x |
| Cg Oncology, Inc. | CGON | ██% | $5.68B | -x |
| Cognition Therapeutics Inc | CGTX | ██% | $112M | -x |
| Coherus Oncology, Inc. | CHRS | ██% | $242M | 1,3x |
| Calidi Biotherapeutics, Inc. | CLDI | ██% | $4M | -x |
| Cellectis S.A. | CLLS | ██% | $354M | -x |
| Compass Therapeutics, Inc. | CMPX | ██% | $348M | -x |
| Mosaic Immunoengineering Inc. | CPMV | ██% | $5M | -x |
| Caribou Biosciences, Inc. | CRBU | ██% | $142M | -1,5x |
| Cardiff Oncology, Inc. | CRDF | ██% | $122M | -x |
| Cardiol Therapeutics Inc. | CRDL | ██% | $151M | -x |
| Curis Inc | CRIS | ██% | $20M | -x |
| Crispr Therapeutics Ag | CRSP | ██% | $4.81B | -x |
| Champions Oncology, Inc. | CSBR | ██% | $83M | -x |
| Cel Sci Corp | CVM | ██% | $21M | -x |
| Dbv Technologies S.A. | DBVT | ██% | $1.10B | -x |
| Dbv Technologies S.A. | DBVTF | ██% | $10K | -x |
| Ginkgo Bioworks Holdings, … | DNA | ██% | $498M | -x |
| Denali Therapeutics Inc. | DNLI | ██% | $3.06B | -x |
| Precision Biosciences Inc | DTIL | ██% | $185M | -x |
| Dyadic International Inc | DYAI | ██% | $27M | -x |
| Editas Medicine, Inc. | EDIT | ██% | $261M | -x |
| Eloxx Pharmaceuticals, Inc. | ELOX | ██% | $5M | -x |
| Elutia Inc. | ELUT | ██% | $52M | 1,0x |
| Engene Therapeutics Inc. | ENGN | ██% | $116M | -x |
| Entera Bio Ltd. | ENTX | ██% | $59M | -x |
| Viskase Holdings, Inc. | ENZN | ██% | $38M | -x |
| Estrella Immunopharma, Inc. | ESLA | ██% | $48M | -x |
| Evaxion A/S | EVAX | ██% | $34M | -x |
| Exelixis, Inc. | EXEL | ██% | $12.60B | 15,1x |
| Exozymes Inc. | EXOZ | ██% | $80M | -x |
| Fate Therapeutics Inc | FATE | ██% | $244M | -x |
| 4d Molecular Therapeutics, … | FDMT | ██% | $454M | -x |
| Fennec Pharmaceuticals Inc. | FENC | ██% | $344M | -x |
| Finch Therapeutics Group, … | FNCH | ██% | $12M | 0,5x |
| Finch Therapeutics Group, … | FNCHQ | ██% | $12M | 0,5x |
| Futuretech Ii Acquisition … | FTII | ██% | $52M | -x |
| Futuretech Ii Acquisition … | FTIIU | ██% | $14M | -x |
| Gilead Sciences, Inc. | GILD | ██% | $162.08B | 17,6x |
| Monte Rosa Therapeutics, … | GLUE | ██% | $1.59B | -x |
| Genenta Science S.P.A. | GNTA | ██% | $14M | -x |
| Green Planet Bio … | GPLB | ██% | N/A | -x |
| Greenland Mines Ltd | GRML | ██% | $47M | -x |
| Halozyme Therapeutics, Inc. | HALO | ██% | $8.12B | 23,3x |
| Humacyte, Inc. | HUMA | ██% | $226M | -x |
| Immunitybio, Inc. | IBRX | ██% | $8.11B | -x |
| Inhibikase Therapeutics, Inc. | IKT | ██% | $230M | -x |
| Imagenebio, Inc. | IMA | ██% | $62M | -x |
| Immunocore Holdings Plc | IMCR | ██% | $1.52B | -x |
| Immatics N.V. | IMTX | ██% | $1.48B | -x |
| Immunovant, Inc. | IMVT | ██% | $6.96B | -x |
| In8bio, Inc. | INAB | ██% | $17M | -x |
| Inhibrx Biosciences, Inc. | INBX | ██% | $873M | -6,8x |
| Mink Therapeutics, Inc. | INKT | ██% | $52M | -x |
| Inmune Bio, Inc. | INMB | ██% | $38M | -x |
| Intensity Therapeutics, Inc. | INTS | ██% | $12M | -x |
| Iovance Biotherapeutics, Inc. | IOVA | ██% | $1.62B | -x |
| Century Therapeutics, Inc. | IPSC | ██% | $409M | -x |
| Invivyd, Inc. | IVVD | ██% | $314M | -x |
| Jasper Therapeutics, Inc. | JSPR | ██% | $24M | -x |
| Kalaris Therapeutics, Inc. | KLRS | ██% | $118M | -x |
| Klotho Neurosciences, Inc. | KLTO | ██% | $56M | -x |
| Kodiak Sciences Inc. | KOD | ██% | $2.33B | -x |
| Krystal Biotech, Inc. | KRYS | ██% | $8.96B | 39,8x |
| Kymera Therapeutics, Inc. | KYMR | ██% | $6.62B | -x |
| Kyverna Therapeutics, Inc. | KYTX | ██% | $539M | -x |
| Ladrx Corp | LADX | ██% | $20K | -x |
| Lineage Cell Therapeutics, … | LCTX | ██% | $329M | -x |
| Lenz Therapeutics, Inc. | LENZ | ██% | $236M | -x |
| Atyr Pharma Inc | LIFE | ██% | $2.03B | -x |
| Liminatus Pharma, Inc. | LIMN | ██% | $11M | -x |
| Leonabio, Inc. | LONA | ██% | $95M | -x |
| Lexeo Therapeutics, Inc. | LXEO | ██% | $387M | -x |
| Maze Therapeutics, Inc. | MAZE | ██% | $1.43B | -x |
| Mesoblast Ltd | MESO | ██% | $1.94B | -x |
| Meiragtx Holdings Plc | MGTX | ██% | $879M | -x |
| Metagenomi Therapeutics, Inc. | MGX | ██% | $49M | -x |
| Molecular Partners Ag | MOLN | ██% | $153M | -x |
| Moderna, Inc. | MRNA | ██% | $18.76B | -x |
| Neurocrine Biosciences Inc | NBIX | ██% | $15.64B | 23,4x |
| Nkgen Biotech, Inc. | NKGN | ██% | $2M | -0,1x |
| Neumora Therapeutics, Inc. | NMRA | ██% | $333M | -x |
| Novavax Inc | NVAX | ██% | $1.48B | -x |
| Ocugen, Inc. | OCGN | ██% | $457M | -x |
| Outlook Therapeutics, Inc. | OTLK | ██% | $40M | -x |
| Palisade Bio, Inc. | PALI | ██% | $337M | -x |
| Passage Bio, Inc. | PASG | ██% | $17M | -x |
| Vaxcyte, Inc. | PCVX | ██% | $6.84B | -x |
| Biomx Inc. | PHGE | ██% | $7M | -x |
| Pluri Inc. | PLUR | ██% | $24M | -x |
| Protalix Biotherapeutics, Inc. | PLX | ██% | $162M | 10,6x |
| Pharmacyte Biotech, Inc. | PMCB | ██% | $9M | -x |
| Prime Medicine, Inc. | PRME | ██% | $533M | -x |
| Prokidney Corp. | PROK | ██% | $529M | -x |
| Pelthos Therapeutics Inc. | PTHS | ██% | $91M | -x |
| Qiagen N.V. | QGEN | ██% | $7.57B | -x |
| Quince Therapeutics, Inc. | QNCX | ██% | $21M | 2,4x |
| Qrons Inc. | QRON | ██% | $150K | -x |
| Replimune Group, Inc. | REPL | ██% | $416M | -x |
| Repligen Corp | RGEN | ██% | $6.39B | 124,4x |
| Regenxbio Inc. | RGNX | ██% | $348M | -x |
| Relay Therapeutics, Inc. | RLAY | ██% | $2.58B | -x |
| Revolution Medicines, Inc. | RVMD | ██% | $30.77B | -x |
| Recursion Pharmaceuticals, Inc. | RXRX | ██% | $1.65B | -x |
| Sab Biotherapeutics, Inc. | SABS | ██% | $291M | -x |
| Sana Biotechnology, Inc. | SANA | ██% | $850M | -x |
| Scilex Holding Co | SCLX | ██% | $42M | -x |
| Scinai Immunotherapeutics Ltd. | SCNI | ██% | $2M | -x |
| Sangamo Therapeutics, Inc | SGMO | ██% | $62M | -x |
| Solid Biosciences Inc. | SLDB | ██% | $640M | -x |
| Silexion Therapeutics Corp | SLXN | ██% | $2M | -x |
| Senti Biosciences Holdings, … | SNTI | ██% | $31M | -x |
| Scholar Rock Holding … | SRRK | ██% | $5.68B | -x |
| Surrozen, Inc./De | SRZN | ██% | $311M | -x |
| Sutro Biopharma, Inc. | STRO | ██% | $507M | -x |
| Protara Therapeutics, Inc. | TARA | ██% | $262M | -x |
| Tarsus Pharmaceuticals, Inc. | TARS | ██% | $2.73B | -x |
| Tc Biopharm (Holdings) … | TCBPY | ██% | $10K | -x |
| Tscan Therapeutics, Inc. | TCRX | ██% | $67M | -x |
| Bio-Techne Corp | TECH | ██% | $7.10B | 64,8x |
| Tectonic Therapeutic, Inc. | TECX | ██% | $541M | -x |
| Instil Bio, Inc. | TIL | ██% | $54M | -x |
| Tenaya Therapeutics, Inc. | TNYA | ██% | $170M | -x |
| Tourmaline Bio, Inc. | TRML | ██% | $1.23B | -3,5x |
| Taysha Gene Therapies, … | TSHA | ██% | $1.57B | -x |
| Titan Pharmaceuticals Inc | TTNP | ██% | $6M | -0,5x |
| Tevogen Bio Holdings … | TVGN | ██% | $41M | -x |
| Twist Bioscience Corp | TWST | ██% | $3.29B | -x |
| Voyager Acquisition Corp./Cayman … | VACH | ██% | $364M | 54,0x |
| Voyager Acquisition Corp./Cayman … | VACHU | ██% | $68M | 6,7x |
| Valneva Se | VALN | ██% | $546M | -x |
| Vericel Corp | VCEL | ██% | $1.80B | 84,0x |
| Vir Biotechnology, Inc. | VIR | ██% | $1.43B | -x |
| Vivosim Labs, Inc. | VIVS | ██% | $3M | -x |
| Vor Biopharma Inc. | VOR | ██% | $805M | -x |
| Vaxart, Inc. | VXRT | ██% | $150M | 4,0x |
| Voyager Therapeutics, Inc. | VYGR | ██% | $214M | -x |
| Windtree Therapeutics Inc … | WINT | ██% | $670K | -x |
| X4 Pharmaceuticals, Inc | XFOR | ██% | $371M | -x |
| Zeo Scientifix, Inc. | ZEOX | ██% | $14M | -x |
| Zivo Bioscience, Inc. | ZIVO | ██% | $14M | -x |
| Zura Bio Ltd | ZURA | ██% | $410M | -x |
الأسئلة الشائعة
-
هل Atara Biotherapeutics, Inc. سهم جيد للشراء؟
يحلل ذكاؤنا الاصطناعي Atara Biotherapeutics, Inc. يومياً. تحقق من الإشارة أعلاه لأحدث توصية. قم دائماً بإجراء بحثك الخاص قبل الاستثمار.
-
ما مدى دقة تنبؤات Atara Biotherapeutics, Inc.؟
يحقق ذكاؤنا الاصطناعي ارتباط سبيرمان بنسبة 3% لهذا السهم، بمتوسط دقة أكثر من 67% عبر أكثر من 4,000 سهم يتم تحليلها يومياً.
-
كم مرة يتم تحديث التنبؤات؟
يتم تحديث تنبؤات Atara Biotherapeutics, Inc. يومياً باستخدام أحدث بيانات السوق ونماذج الذكاء الاصطناعي.
هل أنت مستعد للاستثمار بذكاء أكبر؟
انضم إلى آلاف المستثمرين الذين يستخدمون تنبؤات الأسهم المدعومة بالذكاء الاصطناعي
سجّل مجاناً✓ حساب مجاني · ✓ أكثر من 4,000 سهم · ✓ تحديثات يومية
هل تبحث عن تحليل أعمق لـ Atara Biotherapeutics, Inc.؟
عرض التحليل المؤسسي الكامل على Intratio →تستند تنبؤات الذكاء الاصطناعي إلى الأنماط التاريخية ولا ينبغي أن تكون الأساس الوحيد لقرارات الاستثمار. الأداء السابق لا يضمن النتائج المستقبلية. قم دائماً بإجراء بحثك الخاص.